Privately held Roentec, based in
Bruker claims the worldwide X-ray microanalysis market to be north of $150 million and said it "has not participated" in it. Typical applications of X-ray microanalysis include nanotechnology and "advanced materials research."
Selling its products "primarily" in
Roentec CEO Thomas Schuelein said in a statement today that Bruker's global distribution muscle "can ... enhance the revenue growth" for the company's mobile microXRF and TXRF systems.
Frank Burgaezy, executive vice president at Bruker AXS, agreed, saying in the statement that Roentec, though it has "a strong customer base in certain geographical markets, ... has been distribution-limited and at a size disadvantage relative to its larger competitors."
According to Bruker, the X-ray microanalysis market comprises X-ray accessories for scanning and transmission-electron microscopes and stand-alone micro-X-ray fluorescence spectrometers.
Though Bruker AXS plays in the X-ray diffraction space for advanced materials and nanotechnology research, in X-ray single crystal diffraction for small molecule and protein 3D structural analysis, and in X-ray fluorescence elemental analysis for a variety of materials-analysis and quality-control applications, the company has not participated in X-ray microanalysis, which it calls a "fourth important" X-ray analysis market.
News of the acquisition comes almost exactly two months after Bruker AXS said it would buy French X-ray analysis-software company Socabim for an undisclosed sum.
As GenomeWeb News reported in August, Socabim has already been providing software for X-ray diffraction and X-ray fluorescence materials analysis to Bruker AXS. Bruker plans to merge Socabim with its own French subsidiary near
Socabim employees are expected to remain with the company following the acquisition, which is expected to close in the first quarter of 2006.
"We believe that with the addition of the Socabim technology and R&D team, our products can accelerate their 'time-to-market,' and our X-ray systems for advanced research and process analysis [...] will be even more powerful and user-friendly," Frank Burgazy, managing director of Bruker AXS and president of the French subsidiary, said in a statement.